Abstract Objectives Idiopathic Burning mouth syndrome (iBMS) is a poorly understood
affection characterized by persistent pain in the oral cavity without any clinical or biological …

Objectives Opiorphin is a pentapeptide isolated from human saliva that suppresses pain
from chemically induced inflammation and acute physical pain. Burning mouth syndrome …

Objective Burning mouth syndrome (BMS) is a chronic oral pain condition with unknown
aetiology but assumed to involve peripheral/central neuropathological and immune …

Objectives: Opiorphin is an enkephalinase inhibitor which suppresses pain by acting on the
opioid system. The levels of opiorphin in plasma and saliva have shown to vary in patients …

Background Burning mouth syndrome (BMS) is a frequently occurring disease characterized
by a burning or painful sensation in the tongue and/or other oral sites without clinical …

Aim Burning mouth syndrome could be considered an expression of atypical facial pain. The
recent neuropathological findings in BMS may suggest the need for alternative therapies …

METHODS This research was approved by the Ethics Committee of Hospital das Clinicas,
Medical School, University of Sao Paulo (HC-FMUSP), and all patients provided informed …

Background: Burning mouth syndrome (BMS) is an enigmatic condition with the
etiopathogenesis remaining largely obscure. However, a neuropathic basis for BMS …

Objective Burning mouth syndrome (BMS) is a chronic intraoral burning sensation with no
identifiable causes. In this study, we aim to demonstrate the effectiveness of treatment …

Oral Diseases (2010) 16, 643–647 Background: The symptoms associated with burning
mouth syndrome can be quite varied and can interfere with the every day lives of patients …